LCM
MYGN icon

Laurion Capital Management’s Myriad Genetics MYGN Stock Holding History

Laurion Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65K Buy
+14,443
New +$75.3K 0.01% 336
2020
Q3 		– Sell
-23,606
Closed -$268K – 1068
2020
Q2 		$268K Buy
+23,606
New +$335K 0.01% 742
2017
Q3 		– Sell
-20,600
Closed -$532K – 1829
2017
Q2 		$532K Buy
+20,600
New +$437K 0.01% 1235
2015
Q3 		– Sell
-44,940
Closed -$1.53M – 913
2015
Q2 		$1.53M Buy
+44,940
New +$1.53M 0.07% 410

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return